Nonassociation of interleukin-1 receptor antagonist genotypes with bone mineral density, bone turnover status, and estrogen responsiveness in Korean postmenopausal women

Bone

Volumn 31, Issue 5, 2002, Pages 612-615

  Han, Kiok O ^a   Choi, J T ^b   Moon, I G ^c   Jeong, M S ^c   Yim, C H ^a   Chung, H Y ^a   Jang, H C ^a   Yoon, H K ^a   Han, I K ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Organon Korea ^*  (South Korea)

^c Samsung Advanced Institute of Technology (SAIT)   (South Korea)

Author keywords

Bone mass; Genetics; Hormone replacement therapy (HRT); Interleukin 1 receptor antagonist (IL 1ra); Osteoporosis; Polymorphism

Indexed keywords

ESTROGEN; HORMONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; IL1RN PROTEIN, HUMAN; SIALOGLYCOPROTEIN;

ADULT; AGED; ALLELE; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CONTROLLED STUDY; DNA POLYMORPHISM; ESTROGEN RESPONSIVE ELEMENT; FEMALE; FEMUR NECK; GENE FREQUENCY; GENOTYPE; HORMONE SUBSTITUTION; HUMAN; KOREA; LUMBAR SPINE; NORMAL HUMAN; POSTMENOPAUSE; STATISTICAL SIGNIFICANCE; VARIABLE NUMBER OF TANDEM REPEAT; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; DRUG EFFECT; ESTROGEN THERAPY; GENETIC POLYMORPHISM; GENETICS; LUMBAR VERTEBRA; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; STATISTICS;

ADULT; AGED; ANALYSIS OF VARIANCE; BONE DENSITY; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FEMUR NECK; GENOTYPE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; KOREA; LUMBAR VERTEBRAE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POLYMORPHISM, GENETIC; SIALOGLYCOPROTEINS; STATISTICS, NONPARAMETRIC;

EID: 1842848028     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(02)00873-6     Document Type: Article

References (21)

1. Bajnok E., Takacs I., Vargha P., Speer G., Nagy Z., Lakatos P. Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women. Bone. 27:2000;559-562.
2. Danis V.A., Millington M., Hyland V.J., Grennan D. Cytokines production by normal human monocytes Inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism . Clin Exp Immunol. 99:1995;303-310.
3. Dequeker J., Nijs J., Verstraeten A., Geusens P., Gevers G. Genetic determinants of bone mineral content at the spine and radius A twin study . Bone. 8:1987;207-209.
4. Dinarello C.A. Interleukin-1 and interleukin-1 antagonism. Blood. 777:1991;1627-1652.
5. Keen R.W., Woodford-Richens K.L., Lanchbury J.S., Spector T.D. Allelic variation at the interleukin-1 receptor antagonist gene is associated with early postmenopausal bone loss at the spine. Bone. 23:1998;367-371.
6. Kelly P.J., Eisman J.A., Sambrook P.N. Interaction of genetic and environmental influences on peak bone density. Osteopor Int. 1:1990;56-60.
7. Kelly P.J., Hopper J.L., Macaskill G.T., Pocock N.A., Sambrook P.N., Eisman J.A. Genetic factors in bone turnover. J Clin Endocrinol Metab. 72:1991;808-813.
8. Khosla S., Peterson J.M., Egan K., Jones J.D., Riggs B.L. Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab. 79:1994;707-711.
9. Kimble R.B., Vannice J.L., Bloedow D.C., Thompson R.C., Hopfer W., Kung V.T., Brownfield C., Pacifici R. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest. 93:1994;1959-1967.
10. Langdahl B.L., Lokke E., Carstens M., Stenkjaer L.L., Eriksen E.F. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1-receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J Bone Miner Res. 15:2000;402-414.
11. Pacifici R. Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res. 11:1996;1043-1051.
12. Pacifici R., Brown C., Puscheck E., Friedrich E., Slatopolsky E., Maggio D., McCracken R., Avioli L.V. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA. 88:1991;5134-5138.
13. Pacifici R., Rifas L., McCracken R., Vered I., McMurtry C., Avioli L.V., Peck W.A. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA. 86:1989;2398-2402.
14. Pacifici R., Vannice J.L., Rifas L., Kimble R.B. Monocytic secretion of interleukin-1 receptor antagonist in normal and osteoporotic women Effects of menopause and estrogen/progesterone therapy . J Clin Endocrinol Metab. 77:1993;1135-1141.
15. Patterson D., Jones C., Hart I., Bleskan J., Berger R., Geyer D., Eisenberg S.P., Smith M.F. Jr., Arend W.P. The human interleukin-1 receptor antagonist (IL1RN) gene is located in the chromosome 2q14 region. Genomics. 15:1993;173-176.
16. Pioli G., Basini G., Pedrazzoni M., Musetti G., Ulietti V., Bresciani D., Villa P., Bacchi A., Hughes D., Russell G., Passeri M. Spontaneous release of interleukin-1 and interleukin-6 by peripheral blood monocytes after ovariectomy. Clin Sci. 83:1992;503-507.
17. Pocock N.A., Eisman J.A., Hopper J.L., Yeates M.G., Sambrook P.N., Eberl S. Genetic determinants of bone mass in adults. A twin study. J Clin Invest. 80:1987;706-710.
18. Ralston S.H., Lusk S.A., Gallagher S.J., Boyle I.T. Evidence for enhanced cytokine gene expression in osteoporosis Analysis by mRNA phenotyping using the polymerase chain reaction . Calcif Tissue Int. 44:1992;356-360.
19. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker B., Williams T.C., Lubahn D.B., Korach K.S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 331:1994;1056-1061.
20. Tarlow J.K., Blakemore A.I.F., Lennard A., Solari R., Hughes H.N., Steinkasserer A., Duff G.W. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 91:1993;403-404.
21. Tokita A., Kelly P.J., Nguyen T.V., Qi J.-C., Morrison N.A., Risteli L., Risteli J., Sambrook P.N., Eisman J.A. Genetic determinants of type I collagen synthesis and degradation Further evidence for genetic regulation of bone turnover . J Clin Endocrinol Metab. 78:1994;1461-1466.